Opinion statement Thyroid cancer is an uncommon tumor accounting for roughly 1% of all
new malignancies. Differentiated (ie, papillary or follicular) thyroid carcinoma is usually …

Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

Differentiated thyroid cancer, which includes papillary and follicular histologies, is a common
malignancy and is increasing in incidence. It carries a favorable prognosis compared to …

In the past decade, the management of differentiated thyroid carcinoma changed
significantly and thus contributed to the improvement of the already favorable prognosis of …

Papillary and follicular thyroid cancers, together termed differentiated thyroid cancers (DTC),
comprise the majority of thyroid carcinomas and have an optimal prognosis. Most DTCs …

Controversy continues regarding the optimal management of patients with differentiated
thyroid cancer because no prospective randomized studies evaluating the merits of (1) …

Well-differentiated thyroid carcinoma remains a relatively uncommon diagnosis with a
favorable prognosis. Treatment algorithms continue to evolve with the emergence of new …

Thyroid cancer is the most common endocrine malignancy, although representing fewer
than 1% of all human tumors. Differentiated thyroid carcinoma (DTC) includes the papillary …

Thyroid cancer is rapidly increasing in incidence, but the mortality rate remains flat. Debate
has arisen over the need to detect or treat most thyroid cancers early, given their favorable …

Thyroid cancer can be largely classified as well-differentiated, poorly differentiated,
medullary and anaplastic. Differentiated thyroid cancer (DTC) includes follicular and …